GLOBAL SOLUTIONS INFECTIOUS DISEASES

Brand Owner Address Description
GSID Global Solutions for Infectious Diseases 3527 Mt. Diablo Blvd., #472 Lafayette CA 94549 GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES;charitable medical consulting services in the field of disease prevention and disease control;Research and development of vaccines and pharmaceutical preparations; research, development, engineering and testing services in the fields of pharmaceutical preparations and vaccines; providing clinical and scientific research information in the field of pharmaceuticals, clinical trials, and epidemiological studies; clinical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; conducting early evaluations, namely, scientific research in the field of new pharmaceuticals; research and development of new products for others to diagnose infectious diseases; research and development of new products for others that support the surveillance of infectious diseases; conducting epidemiological studies; charitable services, namely, developing vaccines and pharmaceuticals to prevent infectious diseases; and, planning and conducting epidemiological studies and pharmaceutical research and development;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides compositions for the treatment, inhibition or prevention of diseases or disorders, including cancer, immune diseases or disorders, and infectious diseases, comprising interferon-producing cells (IPCs) and methods of administering the IPCs. The present invention also provides compositions for the treatment, inhibition or prevention of diseases or disorders, including cancer, immune diseases or disorders, and infectious disease, comprising purified interferon (IFN) from IPCs and methods of administering the IFN. The present invention further provides methods for monitoring the progression of a disease or a disorder such as HIV infection or cancer, comprising measuring the abundance of IPCs in lymphoid organs or blood samples from a subject suffering from a disease or disorder.